Filana Therapeutics's total assets for Q4 2025 were $118.36M, a decrease of -8.77% from the previous quarter. FLNA total liabilities were $43.95M for the fiscal quarter, a -8.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.